Alyeska Investment Group’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-7,709
| Closed | -$922K | – | 486 |
|
|
2019
Q3 | $922K | Buy |
7,709
+6,575
| +580% | +$786K | 0.01% | 300 |
|
|
2019
Q2 | $339K | Sell |
1,134
-1,585
| -58% | -$474K | ﹤0.01% | 376 |
|
|
2019
Q1 | $1.22M | Buy |
2,719
+8
| +0.3% | +$3.6K | 0.02% | 273 |
|
|
2018
Q4 | $1.24M | Buy |
+2,711
| New | +$1.24M | 0.02% | 276 |
|
|
2018
Q3 | – | Sell |
-1,667
| Closed | -$978K | – | 511 |
|
|
2018
Q2 | $978K | Buy |
+1,667
| New | +$978K | 0.01% | 368 |
|
|
2016
Q1 | – | Sell |
-498
| Closed | -$391K | – | 461 |
|
|
2015
Q4 | $391K | Sell |
498
-136
| -21% | -$107K | ﹤0.01% | 351 |
|
|
2015
Q3 | $870K | Buy |
634
+58
| +10% | +$79.6K | 0.01% | 392 |
|
|
2015
Q2 | $1.16M | Buy |
+576
| New | +$1.16M | 0.01% | 376 |
|